Larimar Therapeutics LRMR
$ 6.16
1.23%
Quarterly report 2024-Q3
added 10-30-2024
Larimar Therapeutics EV/EBITDA Ratio 2011-2024 | LRMR
Annual EV/EBITDA Ratio Larimar Therapeutics
2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|
-0.256 | -2.43 | 0.173 | 0.371 | 0.148 | 0.395 | 0.235 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
0.395 | -2.43 | -0.195 |